PharmiWeb.com - Global Pharma News & Resources
31-Aug-2018

ViewRay® to Participate in Upcoming Conferences

CLEVELAND, Aug. 31, 2018 /PRNewswire/ -- ViewRay, Inc. (NASDAQ : VRAY ) announced today that members of the executive management team are scheduled to participate in two upcoming investor conferences.

The Company will first participate in a fireside chat at the B. Riley FBR Annual Healthcare Conference in New York, NY.

Event:

B. Riley FBR Annual Healthcare Conference

Date:

Tuesday, September 4, 2018

Time:

3:00pm ET

Later in the month, the Company will participate in a fireside chat at the Morgan Stanley 16th Annual Global Healthcare Conference in New York, NY.

Event:

Morgan Stanley 16th Annual Global Healthcare Conference

Date:

Thursday, September 13, 2018

Time:

4:40pm ET

An audio webcast of the Company's fireside chat at the Morgan Stanley 16th Annual Global Healthcare Conference will be available on the investor relations section of ViewRay's website at www.viewray.com. A replay of the webcast will be available for 7 days after the date of the presentation.

About ViewRay

ViewRay®, Inc. (Nasdaq : VRAY ), designs, manufactures and markets the MRIdian® radiation therapy system. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purposely built to deliver high-precision radiation without unnecessary beam distortion, and consequently, help to mitigate skin toxicity and other safety concerns that may otherwise arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.

Editor Details

Related Links

Last Updated: 31-Aug-2018